{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-002788","form_type":"8-K","ticker":"NXL","cik":"0001527352","company_name":"Nexalin Technology, Inc.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.834829+00:00","generated_at":"2026-06-03T06:28:20.758704+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nexalin regains Nasdaq minimum bid price compliance","bullets":["Received notice from Nasdaq on April 23, 2024, of compliance with Rule 5550(a)(2).","Regained compliance with minimum bid price requirement for continued listing.","CEO Mark White expressed gratitude to shareholders and reaffirmed commitment to neurostimulation mission."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-002788","json":"https://secwatch.observer/filing/0001829126-24-002788.json","markdown":"https://secwatch.observer/filing/0001829126-24-002788.md","text":"https://secwatch.observer/filing/0001829126-24-002788.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624002788/0001829126-24-002788-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624002788/nexalin_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:28:20.758704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}